SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners (“Frazier”), a Seattle-based, healthcare-focused investment firm, announced today that it has completed its acquisition of BioMatrix Holdings, LLC (“BioMatrix” or the “Company”).

西雅图--（商业新闻短讯）--总部位于西雅图的以医疗保健为重点的投资公司Frazier Healthcare Partners（“Frazier”）今天宣布，已完成对BioMatrix Holdings，LLC（“BioMatrix”或“公司”）的收购。

BioMatrix, headquartered in Plantation, FL, is a leading national provider of home-based infusion services with clinical expertise in neurological diseases, immunology deficiencies and transplants, as well as blood disorders. BioMatrix serves a diversified base of patients with over 2,500 physician-referral relationships across all 50 states.

BioMatrix总部位于佛罗里达州种植园，是国内领先的家庭输液服务提供商，在神经系统疾病、免疫缺陷和移植以及血液疾病方面拥有临床专业知识。BioMatrix为所有50个州的2500多名医生转诊关系的多样化患者提供服务。

The Company delivers a high-touch, patient-centric model built around therapeutic centers of excellence that provide superior management of patient therapies. BioMatrix is well positioned to benefit from the continuing shift of infused therapies to the home and ambulatory setting, as well as the ongoing growth of biologic therapies requiring infusions..

该公司围绕卓越的治疗中心提供了一种高度接触、以患者为中心的模式，为患者治疗提供卓越的管理。BioMatrix处于有利地位，可以从输注疗法向家庭和门诊环境的持续转变以及需要输注的生物疗法的持续增长中受益。。

Frazier is partnering with Ted and Kathee Kramm, two highly experienced industry executives in the home infusion market, to lead BioMatrix. Ted and Kathee began their careers as clinicians (pharmacist and nurse, respectively) and have scaled multiple infusion pharmacy businesses. Most notably, in 2008, they founded AxelaCare, which, over the course of a decade, grew into one of the largest providers of home infusion services in the country.

弗雷泽（Frazier）与两位在家庭输液市场经验丰富的行业高管特德（Ted）和凯西·克拉姆（Kathee Kramm）合作，领导BioMatrix。特德（Ted）和凯西（Kathee Kramm）从临床医生（分别为药剂师和护士）开始职业生涯，并扩展了多家输液药房业务。最值得注意的是，2008年，他们成立了AxelaCare，经过十年的发展，AxelaCare已发展成为国内最大的家庭输液服务提供商之一。

Effective as of the closing, Ted will serve as Chief Executive Officer and Kathee as President of BioMatrix..

。。

“Backing best-in-class operators is a core tenet of our investment strategy, and we are thrilled to back Ted and Kathee,” said Frazier Partner Philip Zaorski. “As they have done previously, our shared vision for this asset is to build a nationally renowned platform that puts the patient at the center of everything we do.”.

Frazier合伙人PhilipZaorski表示：“支持一流运营商是我们投资战略的核心宗旨，我们很高兴支持Ted和Kathee。”。“正如他们之前所做的那样，我们对这项资产的共同愿景是建立一个全国知名的平台，将患者置于我们所做一切的中心。”。

Ted Kramm, CEO, said, “Frazier’s healthcare expertise and commitment to the home infusion space is outstanding. Working with Frazier, BioMatrix has aggressive plans for growth. We will expand our footprint with both new locations and acquisitions. Additionally, we will work with regional and national payers to increase our managed care penetration and add new therapies to our service offering.

首席执行官特德·克拉姆（Ted Kramm）表示：“弗雷泽（Frazier）的医疗保健专业知识和对家庭输液领域的承诺非常出色。与弗雷泽（Frazier）合作，生物矩阵（BioMatrix）有着积极的增长计划。我们将通过新的地点和收购来扩大我们的足迹。此外，我们将与地区和国家支付方合作，以提高我们的管理式护理渗透率，并为我们的服务提供新疗法。

Kathee and I are delighted to be working with the Frazier team and are looking forward to rapid growth.”.

Kathee和我很高兴能与Frazier团队合作，并期待着快速增长。”。

“I have thoroughly enjoyed leading BioMatrix for the last 14 months,” said Kathee Kramm, President of BioMatrix. “During this time, along with our exceptional leadership team and additional staff, we have fully transitioned the organization into a leading home infusion provider. I look forward to Ted joining the company as CEO so I can transition my role to focus on growth and operations and execute at a high level, as we have historically.”.

BioMatrix总裁凯西·克拉姆（KatheeKramm）表示：“在过去的14个月里，我非常喜欢领导BioMatrix。在这段时间里，随着我们出色的领导团队和额外的员工，我们已经将该组织完全转变为领先的家庭输液提供商。我期待着特德（Ted）作为首席执行官加入该公司，以便我可以转变我的角色，专注于增长和运营，并像历史上一样在高水平上执行。”。

Cantor Fitzgerald & Co. and Goodwin Procter LLP served as Frazier’s financial advisor and legal counsel, respectively.

Cantor Fitzgerald＆Co.和Goodwin Procter LLP分别担任Frazier的财务顾问和法律顾问。

About Frazier Healthcare Partners

关于Frazier Healthcare Partners

Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $8 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 32 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies.

Frazier Healthcare Partners成立于1991年，是一家专注于医疗保健行业的私人股本公司。自成立以来，弗雷泽为私人基金和共同投资机会筹集了80多亿美元的资金，并在32年内投资了200多家公司。弗雷泽的理念是与强大的管理团队合作，同时利用其内部运营资源和网络建立卓越的公司。

Frazier is headquartered in Seattle, WA, and invests broadly across the U.S., Canada, and Europe. For more information about Frazier, visit www.frazierhealthcare.com/home..

弗雷泽总部位于华盛顿州西雅图，在美国、加拿大和欧洲进行广泛投资。有关Frazier的更多信息，请访问www.frazierhealthcare.com/home。。

About BioMatrix Holdings, LLC

关于BioMatrix Holdings，LLC

BioMatrix Specialty Infusion Pharmacy, an Inc. 5000 company, is a trusted, independent specialty infusion pharmacy with decades of experience. Our compassionate care team helps patients navigate the often-challenging healthcare environment. We work closely with our patients, as well as their family and their healthcare providers, throughout the patient’s journey, staying focused on continuity of care and optimal clinical outcomes.

BioMatrix Specialty Infusion Pharmacy是一家拥有5000年经验的公司，是一家值得信赖的独立专业输液药房。我们富有同情心的护理团队帮助患者应对经常充满挑战的医疗环境。在患者的整个旅程中，我们与患者及其家人和医疗保健提供者密切合作，专注于护理的连续性和最佳临床结果。

Every day, in every interaction, we are dedicated to making a difference in people's lives..

每天，在每一次互动中，我们都致力于改变人们的生活。。